A cohort study showed that the risk of hospitalization due to COVID-19 was 2.3- to 4.0-fold higher among homozygous for APOE ε4 than among patients with the common APOE ε3/ε3 genotype [135]. The gene discussed is APOE; the disease is COVID-19.